DAVID GRAHAM to Drug Resistance, Microbial
This is a "connection" page, showing publications DAVID GRAHAM has written about Drug Resistance, Microbial.
Connection Strength
1.039
-
Comparable Results of Helicobacter pylori Antibiotic Resistance Testing of Stools vs Gastric Biopsies Using Next-Generation Sequencing. Gastroenterology. 2022 06; 162(7):2095-2097.e2.
Score: 0.189
-
Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci. 2000 Jan; 45(1):68-76.
Score: 0.163
-
Helicobacter pylori infection in India from a western perspective. Indian J Med Res. 2012 Oct; 136(4):549-62.
Score: 0.099
-
DNA sequence analysis of rdxA and frxA from 12 pairs of metronidazole-sensitive and -resistant clinical Helicobacter pylori isolates. Antimicrob Agents Chemother. 2001 Sep; 45(9):2609-15.
Score: 0.046
-
Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch Intern Med. 2001 May 14; 161(9):1217-20.
Score: 0.045
-
Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother. 2001 Apr; 47(4):459-61.
Score: 0.044
-
Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance. Aliment Pharmacol Ther. 2001 Apr; 15(4):513-8.
Score: 0.044
-
Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance. Antimicrob Agents Chemother. 2001 Jan; 45(1):306-8.
Score: 0.044
-
Antibiotic-resistant H. pylori infection and its treatment. Curr Pharm Des. 2000 Oct; 6(15):1537-44.
Score: 0.043
-
Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori. Antimicrob Agents Chemother. 2000 Aug; 44(8):2133-42.
Score: 0.042
-
Furazolidone combination therapies for Helicobacter pylori infection in the United States. Aliment Pharmacol Ther. 2000 Feb; 14(2):211-5.
Score: 0.041
-
Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies. Helicobacter. 1999 Jun; 4(2):106-12.
Score: 0.039
-
Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates. Clin Infect Dis. 1998 Jul; 27(1):84-9.
Score: 0.037
-
Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother. 1997 Aug; 40(2):283-6.
Score: 0.034
-
Successful low-dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole-resistant Helicobacter pylori. Aliment Pharmacol Ther. 1997 Jun; 11(3):523-7.
Score: 0.034
-
Update on Helicobacter pylori research. Eradication. Eur J Gastroenterol Hepatol. 1997 Jun; 9(6):626-8.
Score: 0.034
-
Unsaturated fatty acids and viability of Helicobacter (Campylobacter) pylori. J Clin Microbiol. 1990 May; 28(5):1060-1.
Score: 0.021
-
Stable amoxicillin resistance in Helicobacter pylori. Helicobacter. 2001 Mar; 6(1):79.
Score: 0.011
-
Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob Agents Chemother. 2000 Aug; 44(8):2214-6.
Score: 0.011
-
Sensitivity of amoxicillin-resistant Helicobacter pylori to other penicillins. Antimicrob Agents Chemother. 1999 Jul; 43(7):1803-4.
Score: 0.010
-
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection. Helicobacter. 1996 Dec; 1(4):243-50.
Score: 0.008